Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/45268


The Pharmaceutical Market: Latvia


Description: THE PHARMACEUTICAL MARKET: LATVIA - REVIEW

The Latvian economy experienced a deep contraction in 2009 but the situation has become more stable since the end of 2010. Economic recovery will continue in 2011, although growth will be moderate. Latvia has the second smallest economy in Central & Eastern Europe, and GDP per capita is below average for the region. Health spending in Latvia is expected to increase by a moderate CAGR between 2011 and 2016, in line with GDP growth. Public health expenditure accounts for over half of the total; public funding is sourced entirely through general taxation. Private expenditure is almost wholly on an out-of-pocket basis; insurance schemes remain rare.

The Latvian pharmaceutical market is comparable in size to Lithuania, although per capita spending is above the regional average. The market is dominated by imports which are largely responsible for driving market growth. Latvia has a small number of drug makers which concentrate on former Soviet markets; only around 25% of domestic production is sold locally. R&D capabilities are strong but public spending on R&D is low. The Latvian pharmaceutical market is expected to grow by a moderate CAGR over the next few years.

Latvia was the principle location for biotechnology in the former Soviet Union. The country’s scientists were considered pioneers in the field and their capacity still exists in the present day. The development of biotechnology in Latvia was seriously hindered in the 1990s with the closure of many large factories and plants. However, the pace of development has picked up since Latvia joined the EU in 2004. Whilst Latvia has made progress in biomedicine, it has not yet reached EU levels.

ENHANCED STRATEGIC INTELLIGENCE

These highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:

- Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators.
- Specialised intelligence on OTCs, generics, biologics and biosimilars.
- Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series.
- A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel.
- The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.

HEALTHCARE STATISTICS

A comprehensive tabula review, comprising demographics, epidemiology, health expenditure, hospital and primary care infrastructure & services and healthcare personnel, is additionally included.


Contents: HEALTHCARE STATISTICS

A comprehensive tabula review, comprising demographics, epidemiology, health expenditure, hospital and primary care infrastructure & services and healthcare personnel, is additionally included.

EXECUTIVE SUMMARY
Including Espicom's at a glance strategic analysis and key data projections

MACROENVIRONMENT
Political, economic, legal and demographic analysis

EPIDEMIOLOGY
Disease burden and prevalence

HEALTHCARE
Organisation, expenditure, infrastructure, services and workforce

REGULATORY AFFAIRS
Regulatory developments and marketing registration/authorisation

PRICING & REIMBURSEMENT

DISTRIBUTION CHANNELS

MARKET ANALYSIS
Projections, product development, manufacturing and trade

COMPETITION
Trade associations, trade fairs, company intelligence and competitive strategies

OTC PHARMACEUTICALS

GENERIC PHARMACEUTICALS

BIOLOGICS & BIOSIMILARS

OPPORTUNITIES & CHALLENGES
Espicom's unique strategic analysis

DIRECTORY

METHODOLOGY & SOURCES


Companies Mentioned Farmserviss Magnum Medical Mepha Latvia Recipe Plus Tamro SIA Kalceks Grindex Olainfarm


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/45268

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 13/02/2012 08:05:04
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
The Pharmaceutical Market: Latvia
Web Address:
http://www.researchandmarkets.com/reports/45268
Office Code:
OC8IHINLSNNSS

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (Online Access) - Enterprisewide €5,050.00
Electronic (PDF) - Enterprisewide €5,050.00
Electronic (Online Access) - Single User €775.00
Hard Copy €775.00 + EUR€ 50.00 Shipping/Handling *
Electronic (PDF) - Single User €775.00
* Shipping/Handling is only charged once per order.


Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 13/02/2012 08:05:04

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)